Intravenous Immunoglobulin Replacement Therapy for Persistent COVID-19 in Patients With B-cell Impairment
Clinical trial NCT06159283 · UNKNOWN
Trial details
- NCT number
- NCT06159283
- Sponsor
- Jaehoon Ko
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-18
- Primary completion
- 2025-06-30
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.